Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
May, 25 2026
Dec, 1 2025
Jul, 27 2025
Feb, 7 2026
Dec, 18 2025